125 related articles for article (PubMed ID: 17225281)
1. Vaccines. Study finds Remune reduces risk of virologic failure.
TreatmentUpdate; 2004 Oct; 16(6):3-4. PubMed ID: 17225281
[No Abstract] [Full Text] [Related]
2. Vaccines for HIV--Remune returns.
TreatmentUpdate; 2004 Oct; 16(6):3. PubMed ID: 17219678
[No Abstract] [Full Text] [Related]
3. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
Angel JB; Routy JP; Tremblay C; Ayers D; Woods R; Singer J; Bernard N; Kovacs C; Smaill F; Gurunathan S; Sekaly RP
AIDS; 2011 Mar; 25(6):731-9. PubMed ID: 21330911
[TBL] [Abstract][Full Text] [Related]
4. Vaccines. From Brazil and France: a vaccine against HIV may lower viral load.
TreatmentUpdate; 2005; 17(1):10-1. PubMed ID: 17228459
[No Abstract] [Full Text] [Related]
5. A boost for the immune system.
TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
[TBL] [Abstract][Full Text] [Related]
6. AIDS clinical research for New Yorkers.
GMHC Treat Issues; 2001 May; 15(5):11. PubMed ID: 11548300
[No Abstract] [Full Text] [Related]
7. Remune bites the dust...again.
Vázquez E
Posit Aware; 2001; 12(5):21. PubMed ID: 11688479
[No Abstract] [Full Text] [Related]
8. Remune trials recruiting.
PI Perspect; 1996 Sep; (No 19):17. PubMed ID: 11363901
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic HIV vaccines show promise.
Abbott A
Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679
[No Abstract] [Full Text] [Related]
10. Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen.
Gandhi T; Nagappan V; Cinti S; Wei W; Kazanjian P
Clin Infect Dis; 2007 Oct; 45(8):1085-92. PubMed ID: 17879930
[TBL] [Abstract][Full Text] [Related]
11. First AIDS vaccine trial launched.
Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708
[No Abstract] [Full Text] [Related]
12. Study released on AIDS vaccine results from Thailand.
AIDS Alert; 2009 Dec; 24(12):139. PubMed ID: 20063476
[No Abstract] [Full Text] [Related]
13. Remune response.
Trauger R
Nat Biotechnol; 1998 Apr; 16(4):314. PubMed ID: 9555714
[No Abstract] [Full Text] [Related]
14. Groundhog day.
Kresge KJ; Noble S
IAVI Rep; 2007; 11(2):1-6. PubMed ID: 20210115
[No Abstract] [Full Text] [Related]
15. New vaccines may keep HIV in check.
Heltzer NE
AIDS Read; 2001 Oct; 11(10):486, 504. PubMed ID: 11708080
[No Abstract] [Full Text] [Related]
16. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
Egan MA
Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
[No Abstract] [Full Text] [Related]
17. Remune rejected. (will a manual recount be required?).
Martinez LJ
Res Initiat Treat Action; 2000 Dec; 6(4):23-4. PubMed ID: 11708171
[No Abstract] [Full Text] [Related]
18. Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in Thailand.
Churdboonchart V; Moss RB; Sirawaraporn W; Smutharaks B; Sutthent R; Jensen FC; Vacharak P; Grimes J; Theofan G; Carlo DJ
AIDS; 1998 Aug; 12(12):1521-7. PubMed ID: 9727574
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
20. HIV hope ride on therapeutic vaccine.
AIDS Read; 2005 Jul; 15(7):332. PubMed ID: 16044573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
